Articulate Labs
Private Company
Total funding raised: $3.2M
Overview
Articulate Labs is a private, commercial-stage medical device company developing intelligent, wearable rehabilitation technology. Its core innovation is KneeStim™, the world's first gait-synchronous NMES system, which uses sensors to learn a patient's unique walking pattern and automatically deliver adaptive electrical stimulation to support knee recovery. The company targets the substantial market for knee osteoarthritis and post-surgical rehabilitation by offering a solution that promises to improve patient adherence and outcomes through home-based, data-driven therapy. It operates a B2B2C model, engaging clinicians to prescribe the device while enabling patient use in daily settings.
Technology Platform
Gait-synchronous neuromuscular electrical stimulation (NMES) platform using motion sensors and adaptive algorithms to deliver real-time, personalized muscle stimulation during a patient's natural walking cycle.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes against traditional stationary NMES devices, passive bracing, and digital physical therapy apps. Its primary differentiation is providing active, biomechanically-timed neuromuscular support during real-world walking, a unique value proposition in the rehabilitation market.